---
category: news
title: "A2 Bio to Present at ASCO-GI 2022 on Use of Next Generation Sequencing (NGS) to Identify GI Cancer Patients for Future Tmod™ CAR T Therapy"
excerpt: "A2 Biotherapeutics, Inc. (“A2 Bio”) is a biotechnology company focused on the development of a first-in-class, logic-gated Tmod™ CAR T cell therapy platform to tackle the fundamental challenge in solid tumor treatment—the ability of cancer medicines to distinguish between tumor and normal cells."
publishedDateTime: 2022-01-18T22:02:00Z
originalUrl: "https://apnews.com/press-release/BusinessWire/technology-health-business-tumors-cancer-0a96daf42067443faf1d277e845e60dd"
webUrl: "https://apnews.com/press-release/BusinessWire/technology-health-business-tumors-cancer-0a96daf42067443faf1d277e845e60dd"
type: article

provider:
  name: Associated Press
  domain: apnews.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://apnews.com/images/PaidContent3.png"
    width: 700
    height: 450
    isCached: true

secured: "mCCeyyRftAb0t5esDYcL3NG62HkGdwYSe5IWSERA6gLlzCq6Rz+pw7bdcESyspGSK1sVq4UyE0JBizVWehotgtS96ZB48S5rmavqXa4M3d2GK/OUgsKJeJHKuXHLAdUjcdnfud1VrqfyIRGvjQoTFNvkMDbUNyr9fu23KUe1vsg7A0Q8qbDQNhKBI9A8fJgL62i0tCmwbPRsX0WrXj1wFm5ZSQhc576SGP18UaMzTn42VKpUZx1mP7QsCBA6xNwRx604iRErd9T1mVbDzeVysyC9rJTnlQjOavqT/FSHIp0aByBJIoy7QoIZ9rxZLhqggUcLK/7PqMMPJ4eKL9T5xZ02zrusGGjkVLTNgrU9GgY=;+mBmFTSOWceyin03cj+2Jg=="
---

